Salomon & Ludwin’s Ingevity NGVT Stock Holding History

Salomon & Ludwin’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.1K	Hold	226	–	–	﹤0.01%	1242
2025 Q4	$13.8K	Sell	226 -42	-16%	-$2.28K	﹤0.01%	1200
2025 Q3	$14.7K	Buy	+268	New	+$13.9K	﹤0.01%	1025

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Salomon & Ludwin's NGVT Position: Q1 2026 in Review

Salomon & Ludwin held its Ingevity (NGVT) position steady in Q1 2026 at 226 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Salomon & Ludwin first reported a position in NGVT in Q3 2025 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

Salomon & Ludwin held 226 shares of Ingevity worth $16.1K as of Q1 2026.
Salomon & Ludwin left its Ingevity share count unchanged in Q1 2026.
Ingevity made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1242 holding.
Salomon & Ludwin first reported a position in Ingevity in Q3 2025 and has held it in 3 quarters since.
307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.